लोड हो रहा है...
SARS-CoV-2 pandemic : Time to revive the cyclophilin inhibitor alisporivir
December 2019 saw the emergence of a new epidemic of pneumonia of varying severity, called COVID-19, caused by a newly identified coronavirus, SARS-CoV-2. No therapeutic option is available to treat this infection that has already killed more than 235,000 people worldwide. This Viewpoint summarizes...
में बचाया:
| में प्रकाशित: | Clin Infect Dis |
|---|---|
| मुख्य लेखक: | |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Oxford University Press
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239253/ https://ncbi.nlm.nih.gov/pubmed/32409832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa587 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|